SEC Form 4 · accession 0001213900-18-003253
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Scott Tomsche
Director
Period of report
Mar 19, 2018
Accepted (ET)
Mar 21, 2018 · 2:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Options (Right to buy) | $7.08 | Mar 19, 2018 | A | 15,000 | A | Mar 19, 2021 | Mar 19, 2028 | Common Stock | 15,000 | 15,000 | D |